🔊CEOInterviews

Ralf Kuriyel on inline flow VPX

From Go with the Flow II Expert Panel Discussion | Hosted by Ralf Kuriyel, Repligen (10/27/22) · · Repligen

“Using inline flow VPX instruments allows us to safely and consistently push drug substance concentration to the highest levels without risking critical quality attributes, which is critical for GMP manufacturing and process consistency.”

Ralf Kuriyel
Senior Vice President of Research & Development, REPLIGEN CORP
Policy Impact inline flow VPXdrug substance concentrationGMP manufacturingprocess consistency

On , Ralf Kuriyel, Senior Vice President of Research & Development at REPLIGEN CORP, spoke about inline flow VPX during Go with the Flow II Expert Panel Discussion | Hosted by Ralf Kuriyel, Repligen (10/27/22) on Repligen.

Go with the Flow II Expert Panel Discussion | Hosted by Ralf Kuriyel, Repligen (10/27/22)
Watch on YouTube
Go with the Flow II Expert Panel Discussion | Hosted by Ralf Kuriyel, Repligen (10/27/22)
Repligen
Watch on YouTube
... here at repen Ralph joined repen in 2016 as the senior VP of resch development where he oversees the company's R&D efforts ...
Ralf Kuriyel

About Ralf Kuriyel

Senior Vice President of Research & Development · REPLIGEN CORP

Ralf Kuriyel, Senior Vice President of Research & Development at Repligen, hosted a panel discussion on October 27, 2022, as part of the "Go with the Flow II" expert webinar series. During the session, Kuriyel stated that Repligen is "passionate about pushing our automated systems marrying it with the proper PAT tools" with the goal of providing solutions that make manufacturing less expensive. He also noted that the company is "still in the research, in developmental stage" regarding further uses of flow VPX technology. The panel discussion covered topics including process analytical technology (PAT) and future perspectives on PAT in biologics manufacturing. Panelists discussed the use of inline flow VPX instruments for real-time monitoring of protein concentration during ultrafiltration/diafiltration processes. Challenges discussed included method transfers between groups, building trust in PAT for GMP manufacturing, and the need for stakeholder alignment and training when implementing new technologies.

Profile compiled from Ralf Kuriyel's verified public interviews and appearances. See all quotes & transcripts →

More from Ralf Kuriyel REPLIGEN CORP (RGEN) Full Transcript Explore All Executives